Robuta

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of...

All therapies currently recommended for the management of osteoporosis act mainly to inhibit bone resorption and reduce bone remodeling. PTH and its analog,...

FTSE 250-listed pharmaceuticals group Hikma Pharmaceuticals has signed an agreement with EffRx for the licensing and distribution of osteoporosis treatment...

Researchers have discovered how activating a receptor called GPR133 with a new drug boosts bone formation, offering a potential breakthrough for osteoporosis...

The new findings were presented as an oral presentation at the 2024 European Calcified Tissue Society Congress, held from May 25, 2024, to May 28, 2024.

Anti-osteoporosis medication (AOM) use in patients exposed to glucocorticoids is thought to reduce fractures. We found post-menopausal women using...

Patients with osteoporosis who suffer a fragility fracture at age 80 years or older have better five-year outcomes if they receive treatment for osteoporosis.

Osteoporosis is a condition that causes porous, weak bones that break easily. There are three different types: primary, secondary, or idiopathic osteoporosis.

Dec 15, 2023 - Osteoporosis : Read complete information about Osteoporosis along with symptoms, treatments, causes, early signs, prevention, risk factors, types and stages on...

Osteoporosis (OP) is a widespread skeletal disorder globally, chiefly characterized by reduced bone mass and deterioration of bone microarchitecture